Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DNCL002329

Drug Information
NameP70/AKT inhibitor
CompanyEli Lilly Indianapolis, IN
IndicationCancer
[ICD9: 140-229   ICD10: C00-C96]
Phase I    
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C30H58O10/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-38-21
-23(37-2)22-39-30(36)40-29-26(33)24(20-31)25(32)27(34)28(29)35/h2
3-29,31-35H,3-22H2,1-2H3/t23-,24?,25?,26?,27?,28?,29?/m1/s1
InChIKeyARSOCJAZLCXHOY-OBJQHKCWSA-N
Canonical SMILESCCCCCCCCCCCCCCCCCCOCC(COC(=O)OC1C(C(C(C(C1O)O)O)CO)O)OC    
Isomeric SMILESCCCCCCCCCCCCCCCCCCOC[C@H](COC(=O)OC1C(C(C(C(C1O)O)O)CO)O)OC
FormulaC30H58O10
PubChem Compound IDCID 16760281.
TargetAkt
P70



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543